PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Global glycated hemoglobin testing market by hospitals and clinics • Global glycated hemoglobin testing market by diagnostic laboratories • Global glycated hemoglobin testing market by academic and research institutes • Market opportunity by end-user PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increased adoption of automation in diabetes care • Rising demand for rapid diagnostic tests and POCT • Increasing demand from developing countries PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • Bio-Rad Laboratories • Danaher • EKF Diagnostics • F. Hoffmann-La Roche PART 15: APPENDIX • List of abbreviations Exhibit 01: Global blood testing market Exhibit 02: Global blood testing market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global glycated hemoglobin testing market – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global glycated hemoglobin testing market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 and 2022 Exhibit 18: Customer landscape Exhibit 19: End-user – Market share 2017-2022 (%) Exhibit 20: Comparison by end-user Exhibit 21: Hospitals and clinics – Market size and forecast 2017-2022 ($ mn) Exhibit 22: Hospitals and clinics – Year-over-year growth 2018-2022 (%) Exhibit 23: Diagnostic laboratories – Market size and forecast 2017-2022 ($ mn) Exhibit 24: Diagnostic laboratories – Year-over-year growth 2018-2022 (%) Exhibit 25: R&D funding in diabetes 2013-2016 ($ millions) Exhibit 26: Academic and research institutes – Market size and forecast 2017-2022 ($ mn) Exhibit 27: Academic and research institutes – Year-over-year growth 2018-2022 (%) Exhibit 28: Market opportunity by end-user Exhibit 29: Global glycated hemoglobin testing market – Market share by geography 2017-2022 (%) Exhibit 30: Regional comparison Exhibit 31: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 32: Americas – Year-over-year growth 2018-2022 (%) Exhibit 33: Top 3 countries in Americas Exhibit 34: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 35: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 36: Top 3 countries in EMEA Exhibit 37: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 38: APAC – Year-over-year growth 2018-2022 (%) Exhibit 39: Top 3 countries in APAC Exhibit 40: Market opportunity Exhibit 41: Rise in population aged 65 years and above (% of total) Exhibit 42: R&D funding in diabetes 2015-2016 ($ millions) Exhibit 43: Vendor landscape Exhibit 44: Landscape disruption Exhibit 45: Vendors covered Exhibit 46: Vendor classification Exhibit 47: Market positioning of vendors Exhibit 48: Abbott overview Exhibit 49: Abbott– Business segments Exhibit 50: Abbott – Organizational developments Exhibit 51: Abbott – Geographic focus Exhibit 52: Abbott – Segment focus Exhibit 53: Abbott – Key offerings Exhibit 54: Bio-Rad Laboratories overview Exhibit 55: Bio-Rad Laboratories– Business segments Exhibit 56: Bio-Rad Laboratories– Organizational developments Exhibit 57: Bio-Rad Laboratories – Geographic focus Exhibit 58: Bio-Rad Laboratories – Segment focus Exhibit 59: Bio-Rad Laboratories– Key offerings Exhibit 60: Danaher overview Exhibit 61: Danaher– Business segments Exhibit 62: Danaher– Organizational developments Exhibit 63: Danaher– Geographic focus Exhibit 64: Danaher– Segment focus Exhibit 65: Danaher– Key offerings Exhibit 66: EKF Diagnostics overview Exhibit 67: EKF Diagnostics – Business segments Exhibit 68: EKF Diagnostics – Organizational developments Exhibit 69: EKF Diagnostics – Geographic focus Exhibit 70: EKF Diagnostics – Segment focus Exhibit 71: EKF Diagnostics – Key offerings Exhibit 72: F. Hoffmann-La Roche overview Exhibit 73: F. Hoffmann-La Roche – Business segments Exhibit 74: F. Hoffmann-La Roche – Organizational developments Exhibit 75: F. Hoffmann-La Roche – Geographic focus Exhibit 76: F. Hoffmann-La Roche – Segment focus Exhibit 77: F. Hoffmann-La Roche – Key offerings

Abbott Bio-Rad Laboratories Danaher EKF Diagnostics F. Hoffmann-La Roche